Article
Jena, Germany-The fluorescence in situ hybridization (FISH) assay appears to be a useful, noninvasive method to monitor for tumor recurrence in patients with transitional cell carcinoma of the bladder, according to European researchers.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.